跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMSUL - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
AMSUL
Approved
STANDARD
AMSUL
Swiss Parenterals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
18d146ea4be1a327
Company
Swiss Parenterals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
18d146ea4be1a327
Drug Approval Philippines Name
AMSUL
Product Name
AMSUL
Registration Number
DR-XY46330
Brand Name
AMSUL
Generic Name
Ampicillin (As Sodium) + Sulbactam (As Sodium)
Dosage Form
Powder for Injection
Dosage Strength
500 mg/ 250 mg
Manufacturer
Swiss Parenterals Pvt. Ltd.
Importer
International Apex Pharmaceuticals, Inc.
Distributor
International Apex Pharmaceuticals, Inc.
Issuance Date
29 May 2023
Expiry Date
04 May 2028
Pharmacologic Category
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
18d146ea4be1a327
Type
Standard
Back to Philippines FDA Approvals